Geriatrics
Sex Difference in Control of Low-Density Lipoprotein Cholesterol in Older Patients after Acute Coronary Syndrome
Cohort study of 232 peopleAcute coronary syndrome
Papers on statin + ezetimibe
198 papers60 new in 30 days
Thursday, July 28
Friday, July 1
Giornale Italiano Di Cardiologia
From statin revolution to gene silencing therapy: 50 years of evolution in the treatment of hypercholesterolemia
ReviewStatins
Friday, May 6
Journal of Diabetes Investigation
Current status of low-density lipoprotein cholesterol for primary prevention of coronary artery disease in late-stage elderly persons with type 2 diabetes mellitus: A retrospective, single-center study
Cross-sectional study of 124 peopleCoronary artery disease
Sunday, April 24
Open Heart
Use of lipid-lowering therapy after ischaemic stroke and expected benefit from intensification of treatment
Cohort study of 462 peopleIschemic stroke
Wednesday, February 16
Sunday, December 12
Pharmacoepidemiology and Drug Safety
Use of negative control outcomes to assess the comparability of patients initiating lipid-lowering therapies
Cohort study in peoplePopulations
Friday, December 10
Aging and Disease
The safety and efficacy of Ezetimibe Plus Statins on ASVD and Related Diseases
ReviewStatins
Tuesday, July 27
Saturday, May 22
The Senior Care Pharmacist
Pharmacological Management of Hyperlipidemia in Older individuals
ReviewHyperlipidemia
Wednesday, March 24
Wednesday, December 2
Annals of Agricultural and Environmental Medicine
Hypolipaemic nutraceutics: red yeast rice and Armolipid, berberine and bergamot
ReviewBerberine
Saturday, November 14
Lancet
Efficacy and safety of lowering LDL cholesterol in older patients: a systematic review and meta-analysis of randomised controlled trials
Meta-analysis of randomized trialsInterventions
Thursday, November 12
Lipids in Health and Disease
Pharmacokinetics and pharmacodynamics of HTD1801 (berberine ursodeoxycholate, BUDCA) in patients with hyperlipidemia
Randomized trial in 50 peopleBerberine
Saturday, November 7
Monday, August 31
Tuesday, August 11
The American Journal of Cardiology
Prevalence and Characteristics of Patients With Primary Severe Hypercholesterolemia in a Multidisciplinary Healthcare System
Cross-sectional study of 265,220 peoplePopulations
Friday, June 5
Journal of Clinical Medicine
Age-Dependent Efficacy of Ezetimibe for Low-Density Lipoprotein Cholesterol Reduction in Japanese Patients with or without Type 2 Diabetes Mellitus
Cohort study of 112 peopleEzetimibe
Saturday, November 23
Current Diabetes Reports
Lowering Targeted Atherogenic Lipoprotein Cholesterol Goals for Patients at "Extreme" ASCVD Risk
ReviewInterventions
Sunday, June 30
Fundamental & Clinical Pharmacology
Are lipid-lowering drugs associated with a risk of cataract? A pharmacovigilance study
Study of 14,664 peopleCataract
Wednesday, May 22
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration
Relationship of statins and other cholesterol-lowering medications and risk of amyotrophic lateral sclerosis in the US elderly
Case-control study of 104,500 peopleAmyotrophic lateral sclerosis
Monday, April 1
Wednesday, March 27
Monday, August 27
Tuesday, March 6
Circulation Journal
Best Treatment Strategies With Statins to Maximize the Cardiometabolic Benefits
ReviewStatins
Saturday, December 9
Nature Reviews Disease Primers
Familial hypercholesterolaemia
Wednesday, August 9
BMC Infectious Diseases
Cardiovascular risk and dyslipidemia among persons living with HIV: a review
ReviewDyslipidemia
Tuesday, May 23
Thursday, April 27
European Heart Journal Cardiovascular Pharmacotherapy
Modelling the cost-effectiveness of PCSK9 inhibitors vs. ezetimibe through LDL-C reductions in a Norwegian setting
Computational studyPCSK9 inhibitors
Tuesday, May 10
Journal of the American Pharmacists Association
What's next for dyslipidemia management? The 2013 ACC/AHA Guidelines, the NLA recommendations, and beyond
ReviewDyslipidemia
Saturday, September 22
Lipids in Health and Disease
Nutraceutical pill containing berberine versus ezetimibe on plasma lipid pattern in hypercholesterolemic subjects and its additive effect in patients with familial hypercholesterolemia on stable cholesterol-lowering treatment
Non-randomized trial in 228 peopleBerberine